Rapid Identification of Germline Mutations in Retinoblastoma by Protein Truncation Testing

Archives of Ophthalmology

Volumn 122, Issue 2, 2004, Pages 239-248

  Tsai, Tony ^a   Fulton, Lilia ^a   Smith, Barbara J ^a   Mueller, Rachel L ^a   Gonzalez, Gustavo A ^a   Uusitalo, Marita S ^a,b   O'Brien, Joan M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; RETINOBLASTOMA PROTEIN;

ARTICLE; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; EXON; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; FRAMESHIFT MUTATION; GENE DELETION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC COUNSELING; GERM LINE; GIEMSA STAIN; HEREDITY; HUMAN; KARYOTYPE; NONSENSE MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN FUNCTION; RETINOBLASTOMA; TREATMENT PLANNING; TUMOR SUPPRESSOR GENE;

DNA MUTATIONAL ANALYSIS; DNA PRIMERS; DNA, NEOPLASM; GENES, RETINOBLASTOMA; GENETIC SCREENING; GERM-LINE MUTATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; POLYMERASE CHAIN REACTION; RETINAL NEOPLASMS; RETINOBLASTOMA; RETINOBLASTOMA PROTEIN; RNA, NEOPLASM; SEQUENCE ANALYSIS, DNA;

EID: 0842305648     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.122.2.239     Document Type: Article

References (27)

1. Devesa SS. The incidence of retinoblastoma. Am J Ophthalmol. 1975;80:263-265.
2. Bishop JO, Madson EC. Retinoblastoma: review of the current status. Surv Ophthalmol. 1975;19:342-366.
3. Gurney JG, Smith MA, Ross JA. Cancer among infants. In: Ries LAG, Smith MA, Gurney JG, et al, eds. Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program, 1975-1995. Bethesda, Md: National Cancer Institute Cancer Statistics Branch; 1999:149-156. NIH Publication 99-4649.
4. Pendergrass TW, Davis S. Incidence of retinoblastoma in the United States. Arch Ophthalmol. 1980;98:1204-1210.
5. Wiggs JL, Dryja TP. Predicting the risk of hereditary retinoblastoma. Am J Ophthalmol. 1988;106:346-351.
6. Wong FL, Boice JD Jr, Abramson DH, et al. Cancer incidence after retinoblastoma: radiation dose and sarcoma risk. JAMA. 1997;278:1262-1267.
7. Vogel F. Genetics of retinoblastoma. Hum Genet. 1979;52:1-54.
8. Sippel KC, Fraioli RE, Smith GD, et al. Frequency of somatic and germ-line mosaicism in retinoblastoma: implications for genetic counseling. Am J Hum Genet. 1998;62:610-619.
9. Friend SH, Bernards R, Rogeli S, et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature. 1986;323:643-646.
10. Lee WH, Bookstein R, Hong F, Young LJ, Shew JY, Lee EY. Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science. 1987;235:1394-1399.
11. Fung YK, Murphree AL, T'Ang A, Qian J, Hinrichs SH, Benedict WF. Structural evidence for the authenticity of the human retinoblastoma gene. Science. 1987;236:1657-1661.
12. Harbour JW. Overview of RB gene mutations in patients with retinoblastoma: implications for clinical genetic screening. Ophthalmology. 1998;105:1442-1447.
13. Zhang K, Wang MX, Munier F, et al. Molecular genetics of retinoblastoma. Int Ophthalmol Clin. 1993;33:53-65.
14. Roest PA, Roberts RG, Sugino S, van Ommen GJ, den Dunnen JT. Protein truncation test (PTT) for rapid detection of translation-terminating mutations. Hum Mol Genet. 1993;2:1719-1721.
15. Den Dunnen JT, Van Ommen GJ. The protein truncation test: a review. Hum Mutat. 1999;14:95-102.
16. Chibon F, Mairal A, Freneaux P, et al. The RB1 gene is the target of chromosome 13 deletions in malignant fibrous histiocytoma. Cancer Res. 2000;60:6339-6345.
17. Rowan AJ, Bodmer WF. Introduction of a myc reporter tag to improve the quality of mutation detection using the protein truncation test. Hum Mutat. 1997;9:172-176.
18. Fujita T, Ohtani-Fujita N, Sakai T, et al. Low frequency of oncogenic mutations in the core promoter region of the RB1 gene. Hum Mutat. 1999;13:410-411.
19. Bunin GR, Emanuel BS, Meadows AT, Buckley JD, Woods WG, Hammond GD. Frequency of 13q abnormalities among 203 patients with retinoblastoma. J Natl Cancer Inst. 1989;81:370-374.
20. Zacksenhaus E, Bremner R, Phillips RA, Gallie BL. A bipartite nuclear localization signal in the retinoblastoma gene product and its importance for biological activity. Mol Cell Biol. 1993;13:4588-4599.
21. Zacksenhaus E, Jiang Z, Hei YJ, Phillips RA, Gallie BL. Nuclear localization conferred by the pocket domain of the retinoblastoma gene product. Biochim Biophys Acta. 1999;1451:288-296.
22. Hu QJ, Dyson N, Harlow E. The regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 large T antigen are common sites for mutations. EMBO J. 1990;9:1147-1155.
23. Blanquet V, Turleau C, Gross-Morand MS, Sénamaud-Beaufort C, Doz F, Besmond C. Spectrum of germline mutations in the RB1 gene: a study of 232 patients with hereditary and non hereditary retinoblastoma. Hum Mol Genet. 1995;4:383-388.
24. Bia B, Cowell JK. Independent constitutional germline mutations occurring in the RB1 gene in cousins with bilateral retinoblastoma. Oncogene. 1995;11:977-979.
25. Dryja TP. Assessment of risk for hereditary retinoblastoma. In: Albert DM, Jakobiec FA, Azar DT, Gragoudas ES, eds. Principles and Practice of Ophthalmology. 2nd ed. Philadelphia, Pa: WB Saunders Co; 2000:5084-5095.
26. Noorani HZ, Khan HN, Gallie BL, Detsky AS. Cost comparison of molecular versus conventional screening of relatives at risk for retinoblastoma. Am J Hum Genet. 1996;59:301-307.
27. Lohmann DR, Brandt B, Hopping W, Passarge E, Horsthemke B. The spectrum of RB1 germ-line mutations in hereditary retinoblastoma. Am J Hum Genet. 1996;58:940-949.